$ Value
—
Shares
9,098
Price
—
Filed
Mar 17
Insider
Name
EDGEMOND JAMES
Title
CFO AND TREASURER
CIK
0001636178
Roles
Transaction Details
Transaction Date
2026-03-15
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
27,662
Footnotes
Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. | Includes 42 shares of common stock acquired on March 4, 2026 under the United Therapeutics Employee Stock Purchase Plan. | Represents the number of shares withheld by United Therapeutics for tax purposes, upon vesting of restricted stock units. | Shares received upon vesting of performance-based restricted stock units on March 15, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. These restricted stock units were granted on March 15, 2023.
Filing Info
EDGEMOND JAMES's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-20 | UTHR | M | $1.4M |
| 2026-04-20 | UTHR | ▼ | $504K |
| 2026-04-20 | UTHR | ▼ | $885K |
| 2026-04-20 | UTHR | ▼ | $254K |
| 2026-04-20 | UTHR | ▼ | $581K |
| 2026-04-20 | UTHR | ▼ | $806K |
| 2026-04-20 | UTHR | ▼ | $397K |
| 2026-04-20 | UTHR | ▼ | $289K |
| 2026-04-20 | UTHR | ▼ | $197K |
| 2026-04-20 | UTHR | ▼ | $284K |
Other Insiders at UTHR (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
ROTHBLATT MARTINE A
Chairperson & CEO
|
— | $193.8M | 2026-04-22 |
| KURZWEIL RAY | — | $2.4M | 2026-03-04 |
| PATUSKY CHRISTOPHER | — | $579K | 2026-04-17 |
|
MAHON PAUL A
EVP & GENERAL COUNSEL
|
— | $25.9M | 2026-04-16 |
| CAUSEY CHRISTOPHER | — | $1.3M | 2026-03-30 |
| Thompson Tommy G | — | $2.1M | 2026-03-26 |
| Olian Judy D. | — | $417K | 2026-03-23 |
|
EDGEMOND JAMES
CFO AND TREASURER
|
— | $50.8M | 2026-04-20 |
|
BENKOWITZ MICHAEL
PRESIDENT AND COO
|
— | $60.0M | 2026-03-15 |
| MALCOLM JAN | — | $97K | 2026-03-17 |